Cargando…

Undetectable Serum Levels of Anti-Müllerian Hormone in Women with Ovarian Hyperstimulation Syndrome during In Vitro Fertilization and Successful Pregnancy Outcome: Case Report

SUMMARY – We report a unique case of undetectable serum levels of anti-müllerian hormone (AMH) in women with polycystic ovary syndrome (PCOS) who developed ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF). A case is described of a 28-year-old woman with clinical symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grbavac, Ivan, Zec, Ivana, Ljiljak, Dejan, Rakoš Justament, Romina, Bukovec Megla, Željka, Kuna, Krunoslav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400342/ https://www.ncbi.nlm.nih.gov/pubmed/30256029 http://dx.doi.org/10.20471/acc.2018.57.01.24

Ejemplares similares

The impact of temporal variability of biochemical markers PAPP-A and free β-hCG on the specificity of the first-trimester Down syndrome screening: a Croatian retrospective study
por: Tišlarić-Medenjak, Dubravka, et al.
Publicado: (2010)

Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome
por: Salmassi, Ali, et al.
Publicado: (2015)

Clinical application of anti-Müllerian hormone as a predictor of controlled ovarian hyperstimulation outcome
por: Lee, Jae Eun, et al.
Publicado: (2012)

Synergetic Effects of K, Ca, Cu and Zn in Human Semen in Relation to Parameters Indicative of Spontaneous Hyperactivation of Spermatozoa
por: Bolanca, Ivan, et al.
Publicado: (2016)

A case of equine cryptorchidism with undetectable serum anti-Müllerian hormone
por: MURASE, Harutaka, et al.
Publicado: (2019)

Correlation of Anti-Mullerian Hormone Level and Antral Follicle Count with Oocyte Number in A Fixed-Dose Controlled Ovarian Hyperstimulation of Patients of In Vitro Fertilization Program
por: Permadi, Wiryawan, et al.
Publicado: (2021)

Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation
por: Izhar, Rubina, et al.
Publicado: (2021)

Severe Ovarian Hyperstimulation Syndrome in the Setting of In Vitro Fertilization Treatment
por: Diaz Ayllon, Hannia, et al.
Publicado: (2023)

Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review
por: Ingold, Caroline, et al.
Publicado: (2023)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization
por: Satwik, Ruma, et al.
Publicado: (2012)

Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues
por: Park, So Yun, et al.
Publicado: (2021)

Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2017)

Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
por: O’Brien, Travis J, et al.
Publicado: (2013)

Fertility Preservation in Endometriosis Patients: Anti-Müllerian Hormone Is a Reliable Marker of the Ovarian Follicle Density
por: Garavaglia, Elisabetta, et al.
Publicado: (2017)

Anti-Müllerian Hormone in Fertility Preservation: Clinical and Therapeutic Applications
por: Sonigo, Charlotte, et al.
Publicado: (2019)

Variant-beta luteinizing hormone is not associated with poor ovarian response to controlled ovarian hyperstimulation
por: Hanevik, Hans I, et al.
Publicado: (2014)

Utrogestan as an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for In Vitro Fertilization
por: Zhu, Xiuxian, et al.
Publicado: (2015)

Anti-mullerian hormone levels before and after ovarian drilling in polycystic ovary syndrome: has this an effect on fertility?
por: Javedani Masroor, Mojgan, et al.
Publicado: (2022)

Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function
por: Moolhuijsen, Loes M E, et al.
Publicado: (2020)

The Effect of Human Growth Hormone on Endometrial Growth in Controlled Ovarian Hyperstimulation Cycles
por: Bavan, Brindha, et al.
Publicado: (2022)

Serum Antimüllerian hormone does not predict elevated progesterone levels among women who undergo controlled ovarian hyperstimulation for in vitro fertilization
por: Kavoussi, Shahryar K., et al.
Publicado: (2019)

Synergistic Regulatory Effect of Inhibin and Anti-Müllerian Hormone on Fertility of Mice
por: Yu, Xue, et al.
Publicado: (2021)

Anti-Müllerian Hormone Serum Values and Ovarian Reserve: Can It Predict a Decrease in Fertility after Ovarian Stimulation by ART Cycles?
por: Patrelli, Tito Silvio, et al.
Publicado: (2012)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Outcomes of Controlled Ovarian Hyperstimulation/In Vitro Fertilization for Infertile Patients with Borderline Ovarian Tumor after Conservative Treatment
por: Park, Chan Woo, et al.
Publicado: (2007)

Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
por: Kojima, Nobue, et al.
Publicado: (2018)

Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone
por: Jamil, Zehra, et al.
Publicado: (2016)

Tubercular Ascites Simulating Ovarian Hyperstimulation Syndrome following In Vitro Fertilization and Embryo Transfer Pregnancy
por: Ramachandran, Amar, et al.
Publicado: (2013)

In-vitro fertilization resulting in heterotopic pregnancy, ovarian hyperstimulation and paralytic ileus: A case report
por: Madžarac, Vedran, et al.
Publicado: (2019)

Relationship between the response to allergen, histamine and hypertonic saline nasal challenge and subjective reactivity to irritants in subjects with seasonal allergic rhinitis
por: Kalogjera, Livije, et al.
Publicado: (2015)

Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis
por: Zadehmodarres, Shahrzad, et al.
Publicado: (2015)

Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function
por: Sinha, Sudwita, et al.
Publicado: (2022)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome
por: Chappell, Neil, et al.
Publicado: (2017)

THU627 Fertility Outcomes And Anti Mullerian Hormone Levels In Women With Hypopituitarism
por: Fitz, Victoria W, et al.
Publicado: (2023)

Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?
por: Yumuşak, Ömer Hamid, et al.
Publicado: (2014)

Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation
por: Sheikhha, Mohammad Hasan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_426e3n52epv205q4tv7kii7jve